Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3052402 | Epilepsy Research | 2011 | 4 Pages |
Abstract
SummaryThe ketogenic diet (KD) is a treatment of infantile spasms (IS). Here, we examine the efficacy of KD in medically refractory IS, examine its impact on growth in infants, and explore its mechanism of action. At 13 months after the initiation of the KD, 46% of twenty-six patients had a greater than 90% reduction in IS. No significant relationships between reduction in IS and serum β-hydroxybutyrate, or glucose levels were identified. Also, the KD had not significantly altered patient's growth parameters. Thus, in corroborating with prior studies, we demonstrate the KD is a well-tolerated and efficacious treatment of IS.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Adam L. Numis, Margaret B. Yellen, Catherine J. Chu-Shore, Heidi H. Pfeifer, Elizabeth A. Thiele,